The MRFF will provide almost $230 million for research into a range of health and medical issues that impact Australians. These include cardiovascular disease, cancer, dementia and cognitive decline, mental health and respiratory disease. Funding is from the MRFF's:
- Clinical Trials Activity initiative ($6.5 million, 3 projects)
- Clinician Researchers initiative ($45.5 million, 33 projects)
- Early to Mid-Career Researchers initiative ($43.3 million, 26 projects)
- Medical Research Commercialisation initiative ($50 million, 1 project)
- Preventive and Public Health Research initiative ($47.9 million, 38 projects)
- Rapid Applied Research Translation initiative ($36.2 million, 9 projects).
Read the media release for information about these projects.
The MRFF will also provide $245 million under the following new grant opportunities:
- $99 million under the 2024 BioMedTech Incubator (guidelines are now available)
- $24 million under the 2024 Cardiovascular Health grant opportunity
- $44.8 million under the 2024 Early to Mid-Career Researchers grant opportunity
- $13.4 million under the 2024 Indigenous Health Research grant opportunity
- $23.7 million under the 2023 Innovative Trials grant opportunity
- $20 million under the 2024 Paediatric Brain Cancer Research grant opportunity
- $20 million under the 2024 Survivorship Care and Collaborative Research Prioritisation grant opportunity.
Visit GrantConnect and the MRFF grant opportunities calendar for details.
Learn more about the MRFF.
/Media Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.